期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 184, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejps.2023.106409
关键词
Tetramethylpyrazine; Dissolving microneedle patches; Rheumatoid arthritis; Transdermal drug delivery system
Recently, transdermal treatment of rheumatoid arthritis (RA) has gained attention for its ability to improve patient compliance and reduce gastrointestinal side effects. In this study, tetramethylpyrazine-loaded dissolving microneedle patches (TMP-DMNPs) were used to effectively deliver TMP through the stratum corneum. In vitro experiments showed that DMNPs promoted transdermal penetration of TMP compared to TMP-cream. Animal models further demonstrated the therapeutic effects of dissolving microneedles in reducing paw swelling and inhibiting synovial tissue damage.
Recently, transdermal treatment of rheumatoid arthritis (RA) has received increasing attention due to the advantages of improving patient compliance and avoiding gastrointestinal side effects. However, the stratum corneum (SC) barrier limits the transdermal delivery of most substances. Therefore, we constructed tetramethylpyrazine-loaded dissolving microneedle patches (TMP-DMNPs) and investigated its antirheumatoid arthritis effect. The cone-shaped dissolving microneedle patch had complete, neatly arranged needles and great mechanical strength. It could effectively penetrate the stratum corneum when applied to the skin. In vitro transdermal experiment showed that DMNPs could significantly promote the transdermal penetration of TMP compared with TMP-cream. The needles were completely dissolved within 18 min and the applied skin recovered completely within 3 h. The excipients and blank DMNP had good safety and biocompatibility to human rheumatoid arthritis fibroblast synovial cells. To compare the therapeutic effects, the animal model was established. The experiments of paw swelling, histopathology and X-ray examination showed that dissolving microneedles significantly alleviated paw condition, reduced the serum concentrations of proinflammatory cytokines, and inhibited synovial tissue damage in AIA rats. These results indicate that the DMNPs we prepared can deliver TMP safely, effectively and conveniently, providing a basis for the percutaneous treatment of RA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据